Quest Diagnostics Incorporated (DGX)
DGX trades on NYSE in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$230.46
-0.93% on the day
Market cap
$25.4B
Large cap
Revenue · 2025
$11.0B
+11.8% on 2024
Net income · 2025
$992.0M
9.0% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | DGX on NYSE |
| Sector | Health Care |
| Industry | Medical Specialities |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001022079 |
| SEC industry code | Services-Medical Laboratories |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $11.0B |
| Net income | $992.0M |
| Operating income | $1.6B |
| Net margin | 9.0% |
| Operating margin | 14.1% |
| Revenue growth | +11.8% |
| Cash | $420.0M |
| Total assets | $16.2B |
| P/E (computed) | 25.6× |
| P/S (computed) | 2.3× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B2 | 2026-04-28 |
| Latest annual report | 10-K | 2026-02-26 |
| Latest quarterly / interim | 10-Q | 2026-07-23 |
| Latest current report CURRENT REPORT | 8-K | 2026-10-06 |
| Latest proxy | DEFA14A | 2026-04-06 |
Source: SEC EDGAR submissions feed, 1,002 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +2.8% |
| 1 month | -5.5% |
| 3 months | +11.5% |
| Year to date | +34.5% |
| 1 year | +27.7% |
| From 52-week high | -5.7% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical Specialities
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| LH | Labcorp Holdings Inc. | $313.64 | -0.60% | $25.4B |
| GH | Guardant Health Inc. | $162.09 | -0.43% | $21.8B |
| CNC | Centene Corporation | $68.86 | +2.75% | $34.0B |
| ILMN | Illumina Inc. | $271.18 | -1.99% | $40.9B |
| HUM | Humana Inc. | $420.38 | -3.03% | $50.5B |
| NTRA | Natera Inc. | $395.65 | -0.53% | $57.0B |
| MOH | Molina Healthcare Inc | $209.50 | +2.52% | $10.9B |
| OSCR | Oscar Health Inc. | $33.79 | -0.65% | $10.4B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier